Method for simultaneous quantification of lipid and nucleic acid components in lipid nanoparticle formulations
The IPRP-HPLC with UV and CAD detection method allows simultaneous quantification of lipid and nucleic acid species in LNPs, addressing the complexity of separate analytical procedures and enhancing formulation characterization and quality control.
Patent Information
- Authority / Receiving Office
- WO · WO
- Patent Type
- Applications
- Current Assignee / Owner
- GENENTECH INC
- Filing Date
- 2025-12-11
- Publication Date
- 2026-06-18
AI Technical Summary
Current methods for analyzing lipid and nucleic acid components in lipid nanoparticles (LNPs) require separate analytical procedures, leading to increased complexity and turnaround time, especially when dealing with complex formulations and diverse lipid libraries.
A method combining ion-pair reversed-phase high-performance liquid chromatography (IPRP-HPLC) with ultraviolet (UV) and charged aerosol detection (CAD) for simultaneous quantification of lipid and nucleic acid species in a single chromatography run, using a single sample preparation protocol.
Enables efficient, accurate, and sensitive quantification of multiple lipid and nucleic acid species in LNPs with reduced analytical time, facilitating comprehensive characterization and quality control of LNP formulations.
Smart Images

Figure US2025059162_18062026_PF_FP_ABST